T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Melanoma

Interventions

DRUG

Cyclophosphamide

DRUG

Fludarabine

BIOLOGICAL

T cells

BIOLOGICAL

Interleukin-2

BIOLOGICAL

Dendritic cell vaccine

Trial Locations (1)

RECRUITING

Karolinska University Hospital, Stockholm

All Listed Sponsors

lead

Karolinska University Hospital

OTHER